Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regranex and Promagran Dressing in Chronic Wound Healing
NCT02845466Phase 3Unknown
- Sponsor
- McMaster University
- Start
- Aug 2018
- Primary completion
- Sep 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous leg ulcer (VLU) and diabetic foot ulcer (DFU) comparing Regranex/Promagran Dressing with Regranex/Placebo Dressing (2 arms). Primary endpoint: Applied Growth Factors in Chronic Wound Fluid at 6 weeks. Status: unknown.
02
Drugs
becaplermin
03
Conditions
venous leg ulcer (VLU)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02845466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845466.